Cardiac output and arteriovenous oxygen difference contribute to lower peak oxygen uptake in patients with fibromyalgia

心输出量和动静脉氧差是导致纤维肌痛患者峰值摄氧量降低的原因。

阅读:1

Abstract

BACKGROUND: Patients with fibromyalgia (FM) exhibit low peak oxygen uptake ([Formula: see text]O(2peak)). We aimed to detect the contribution of cardiac output to ([Formula: see text]) and arteriovenous oxygen difference [Formula: see text] to [Formula: see text] from rest to peak exercise in patients with FM. METHODS: Thirty-five women with FM, aged 23 to 65 years, and 23 healthy controls performed a step incremental cycle ergometer test until volitional fatigue. Alveolar gas exchange and pulmonary ventilation were measured breath-by-breath and adjusted for fat-free body mass (FFM) where appropriate. [Formula: see text] (impedance cardiography) was monitored. [Formula: see text] was calculated using Fick's equation. Linear regression slopes for oxygen cost (∆[Formula: see text]O(2)/∆work rate) and [Formula: see text] to [Formula: see text]O(2) (∆[Formula: see text]/∆[Formula: see text]O(2)) were calculated. Normally distributed data were reported as mean ± SD and non-normal data as median [interquartile range]. RESULTS: [Formula: see text]O(2peak) was lower in FM patients than in controls (22.2 ± 5.1 vs. 31.1 ± 7.9 mL∙min(-1)∙kg(-1), P < 0.001; 35.7 ± 7.1 vs. 44.0 ± 8.6 mL∙min(-1)∙kg FFM(-1), P < 0.001). [Formula: see text] and C(a-v)O(2) were similar between groups at submaximal work rates, but peak [Formula: see text] (14.17 [13.34-16.03] vs. 16.06 [15.24-16.99] L∙min(-1), P = 0.005) and C(a-v)O(2) (11.6 ± 2.7 vs. 13.3 ± 3.1 mL O(2)∙100 mL blood(-1), P = 0.031) were lower in the FM group. No significant group differences emerged in ∆[Formula: see text]O(2)/∆work rate (11.1 vs. 10.8 mL∙min(-1)∙W(-1), P = 0.248) or ∆[Formula: see text]/∆[Formula: see text]O(2) (6.58 vs. 5.75, P = 0.122) slopes. CONCLUSIONS: Both [Formula: see text] and C(a-v)O(2) contribute to lower [Formula: see text]O(2peak) in FM. The exercise responses were normal and not suggestive of a muscle metabolism pathology. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03300635. Registered 3 October 2017-Retrospectively registered. https://clinicaltrials.gov/ct2/show/NCT03300635 .

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。